News

Almost One Third Of Adults Say They Won’t Get The COVID Vaccine Anymore

Misinformation, health concerns, and rollout blunders are creating vaccine hesitancy.

Covid Vaccine

Want more Junkee in your life? Sign up to our newsletter, and follow us on Instagram, Twitter and Facebook so you always know where to find us.

Nearly one-third of Australian adults are cautious about Covid vaccines, a new survey by Fairfax and a partnering research company has found.

15% of unvaccinated respondents said they were “not at all likely”, and 14%  “not very likely” to be vaccinated in the next few months. Fear of possible side effects was noted as the main contributing factor.

The findings come as news outlets are being challenged for publishing stories that highlight deaths and health challenges related to the vaccines.

“The media is playing doctor [and this] is having a material effect on vaccine confidence,” Vice President of the Australian Medical Association, Chris Moy said to the ABC.

On Thursday, May 13, the Australian Press Council closed a complaint against a NewsCorp headline published last December that claimed six people died during a US Pfizer trial.

“By implying in the headline that the deaths were or could have been due to the vaccine, the publication failed to take steps to ensure factual material is not misleading,” the Council found.

Conversations around vaccine hesitancy spiked when some cases of rare blood clots were associated with the AstraZeneca vaccine internationally. The risk rate only 4 to 6 people out of a million, while people on birth control pills are way more likely to experience blood clots.

A poll by the Guardian last month found that less than half of people aged over 50 were open to the AstraZeneca vaccine, despite it being the recommended brand for the demographic because the risk of clots is lower for them.

As of May 3, all Australians over the age of 50 are eligible to receive AstraZeneca jabs.

It’s unclear what specific age range Fairfax sampled for their survey but at this point in time, eligibility for Covid vaccines is still staggered.

High-risk workers, over 70s, Indigenous adults over 50, and people those with underlying medical conditions were prioritised in the phase 1a and 1b.

National Cabinet recommends that the Pfizer vaccine should be prioritised for Australians under 50, according to the Department of Health. Children under 16 are still not eligible for any vaccine brand.

Fairfax’s survey also found another strong reason for vaccine hesitancy is the fact that borders will remain closed until at least 2022 — so there’s no perceived rush from potential candidates.

The government is facing backlash over the pace, and inability to meet deadline for its bungled vaccine rollout.

Nearly 3,200,000 vaccine doses have been administered since Monday, May 17.